⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALZN News
Alzamend Neuro, Inc. Common Stock
Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital
prnewswire.com
ALZN
Form 8-K
sec.gov
ALZN
Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital
prnewswire.com
ALZN